IMRT:Radiobiological Consideration

Authors

  • Nisa Chawapun Division of Therapeutic Radiology and Oncology, Department of Radiology Faculty of Medicine, Chiang Mai University, Chiang Mai, THAILAND

Abstract

Intensity-modulated radiation therapy (IMRT) is a technique of radiation delivery developed to improve target dose confornity and normal tissue sparing. The dose distributions conform tighty to the 3D shape of the target by varying the beam intensity across the shaped fields. The complexity of the technique requires the longer treatment time for one fraction especially in the step and shoot technique. The reported total treatment times are varied from 15 min to as long as 30 min. The impact of such prolonging of time on the biological effects should be concemed.

The doses to normal tissue in IMRT technique is another aspect to be considered. The use of multileaf collimator for shaping the beam that gives rise to more leakage radiation between the leaves, the use of more field that reflects the bigger volume of normal tissue exposed to low dose radiation, and the higher total body dose as the monitor unit in beam modulation increased, these all affect the normal tissue dose. As a consequence, the risks of second malignancies after IMRT are of concem.

Therefore, the benefit and risk of using the IMRT will be focused in this review. The incorporation of biological variable into the treatment planning process to maximize the efficacy of IMRT will be discussed.

References

Puri DR, Chou W, Lee N. Intensity- modulated radion therapy in head and neck cancer: dosimetric advantages and update of clinical results. Am J Clin Oncol. 2005; 28: 415-423

Zhen W, Thompson RB, Eake CA. Intensity-modulated radiation therapy (IMRT): The radiation oncologist's perspective. Medical Dosimetry. 2002; 27: 155-159.

Bucci MK, Bevan A, Roach M. Advances in radiation therapy: Conventional to 3D, to IMRT, to 4D and beyond. CA Cancer J Clin. 2005; 55:117-134.

Bucci M, Xia P, Lee N, et al. Intensity modulated radiation therapy for carcinoma of the nasopharynx: An update of the UCSF experience. Int I Radiat Oncol Biol Phys. 2004; 60: S317-S318

Chong Z. Improved local control with intensity modulated radiation therapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2004; 60: S317

Jabbazi S, Feng M, Lin A, et al. Xerostomia and quality of life (QOL) after parotid sparing IMRT for head and neck cancer: A matched case-control comparison with standard radiotherapy (RT). Int J Radiat Oncol Biol Phys. 2004; 60: S321

Munter MW, Thilmann C, Hof H, et al. Stereotactic intensity modulated radiation therapy and inverse treatment planning for tumors of the head and neck region: Clinical implementation of the step and shoot approach and first clinical results. Radiother Oncol. 2003; 66: 313-321.

Hall EJ, Wuu C. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiation Oncology Biol Phys. 2003; 56: 83-88.

Boice JD, Day NE, Anderson A, et al. Second cancers following radiation treatment for cervical cancer: An international collaboration among cancer registries. J Natl Cancer Inst. 1985; 74: 955-975.

Kry SF, Salehpour M, Followill DS, et al. The calculation risk of secondary malignancies from intensity-modulated radiation therapy. Int I Radiation Oncology Biol Phys. 2005; 62: 1195-1203.

Fowler IF, Weish JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int I Radiation Oncology Biol Phys. 2004; 59: 242-249.

Mu X, Lofroth P, Karison M, et al. The effect of fraction time in intensity modulated radiotherapy: Theoretical and experimental evaluation of an optimisation problem. Radiotherapy and Oncology. 2003; 68:181-187.

Paganetti H. Changes in tumor cell response due to prolonged dose delivery times in fractionated radiation therapy. Int I Radiation Oncology Biol Phys. 2005; 63: 892-900.

Shibamoto Y, Ito M, Sugie C, et al. Recovery from sublethal damage during intermittent exposures in cultured tumor cells: Implications for dose modication in radiosurgery and IMRT. Int I Radiation Oncology Biol Phys. 2004; 59: 1484-1490.

Sterzing F, Munter MW, Schafer M, et al. Radiobiological investigation of dose-rate effects in intensity-modulated radiation therapy. Strahlenther Onkol. 2005;181:42-48.

Wang JZ, Li XA, D'Souza WD, et al. Impact of prolonged fraction delivery times on tumor control: A note of caution for intensity-modulated radiation therapy (IMRT). Int J Radiation Oncology Biol Phys. 2003; 57: 543-552.

Yang Y, Xing L. Towards biologically conformal radiation therapy (BCRT): Selective IMRT dose escalation under the guidance of spatial biology distribution. Med. Phys. 2005; 32:1473-1484.

Downloads

Published

2025-08-09

How to Cite

1.
Chawapun N. IMRT:Radiobiological Consideration. J Thai Assn of Radiat Oncol [internet]. 2025 Aug. 9 [cited 2025 Dec. 26];11(1-3):64-70. available from: https://he01.tci-thaijo.org/index.php/jtaro/article/view/281607

Issue

Section

Original articles